374 related articles for article (PubMed ID: 31404008)
1. Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
Kurokawa Y; Takeuchi H; Doki Y; Mine S; Terashima M; Yasuda T; Yoshida K; Daiko H; Sakuramoto S; Yoshikawa T; Kunisaki C; Seto Y; Tamura S; Shimokawa T; Sano T; Kitagawa Y
Ann Surg; 2021 Jul; 274(1):120-127. PubMed ID: 31404008
[TBL] [Abstract][Full Text] [Related]
2. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
3. Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction.
Yoshikawa T; Takeuchi H; Hasegawa S; Nozaki I; Kishi K; Ito S; Ohi M; Mine S; Hara J; Matsuda T; Hiki N; Kurokawa Y
Gastric Cancer; 2016 Jan; 19(1):143-9. PubMed ID: 25414051
[TBL] [Abstract][Full Text] [Related]
4. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.
Kakeji Y; Yamamoto M; Ito S; Sugiyama M; Egashira A; Saeki H; Morita M; Sakaguchi Y; Toh Y; Maehara Y
Surg Today; 2012 Apr; 42(4):351-8. PubMed ID: 22245924
[TBL] [Abstract][Full Text] [Related]
5. [Optimal surgical approach for esophagogastric junction carcinoma].
Yamashita H; Seto Y
Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):40-4. PubMed ID: 25842812
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
7. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
[TBL] [Abstract][Full Text] [Related]
8. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.
Sakaki A; Kanamori J; Ishiyama K; Kurita D; Oguma J; Daiko H
Langenbecks Arch Surg; 2020 Jun; 405(4):509-519. PubMed ID: 32514766
[TBL] [Abstract][Full Text] [Related]
9. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
10. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic en bloc lower mediastinal lymph node dissection via transhiatal approach for adenocarcinoma of esophagogastric junction.
Sakaguchi M; Hosogi H; Kanaya S
Surg Oncol; 2021 Mar; 36():34-35. PubMed ID: 33285434
[TBL] [Abstract][Full Text] [Related]
12. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.
Hagens ERC; van Berge Henegouwen MI; van Sandick JW; Cuesta MA; van der Peet DL; Heisterkamp J; Nieuwenhuijzen GAP; Rosman C; Scheepers JJG; Sosef MN; van Hillegersberg R; Lagarde SM; Nilsson M; Räsänen J; Nafteux P; Pattyn P; Hölscher AH; Schröder W; Schneider PM; Mariette C; Castoro C; Bonavina L; Rosati R; de Manzoni G; Mattioli S; Garcia JR; Pera M; Griffin M; Wilkerson P; Chaudry MA; Sgromo B; Tucker O; Cheong E; Moorthy K; Walsh TN; Reynolds J; Tachimori Y; Inoue H; Matsubara H; Kosugi SI; Chen H; Law SYK; Pramesh CS; Puntambekar SP; Murthy S; Linden P; Hofstetter WL; Kuppusamy MK; Shen KR; Darling GE; Sabino FD; Grimminger PP; Meijer SL; Bergman JJGHM; Hulshof MCCM; van Laarhoven HWM; Mearadji B; Bennink RJ; Annema JT; Dijkgraaf MGW; Gisbertz SS
BMC Cancer; 2019 Jul; 19(1):662. PubMed ID: 31272485
[TBL] [Abstract][Full Text] [Related]
13. Incidence of lymph node metastasis at each station in Siewert types Ⅱ/Ⅲ adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis.
Chen XD; He FQ; Chen M; Zhao FZ
Surg Oncol; 2020 Dec; 35():62-70. PubMed ID: 32835903
[TBL] [Abstract][Full Text] [Related]
14. Optimal surgical management for esophagogastric junction carcinoma.
Matsuda T; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):560-6. PubMed ID: 24570201
[TBL] [Abstract][Full Text] [Related]
15. Risk factor of mediastinal lymph node metastasis of Siewert type I and II esophagogastric junction carcinomas.
Nishiwaki N; Noma K; Matsuda T; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
Langenbecks Arch Surg; 2020 Dec; 405(8):1101-1109. PubMed ID: 33155069
[TBL] [Abstract][Full Text] [Related]
16. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Yamagishi H
Jpn J Clin Oncol; 2006 Dec; 36(12):775-82. PubMed ID: 17043058
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
[TBL] [Abstract][Full Text] [Related]
18. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study.
Ito H; Inoue H; Odaka N; Satodate H; Suzuki M; Mukai S; Takehara Y; Kida H; Kudo SE
J Exp Clin Cancer Res; 2013 Jan; 32(1):2. PubMed ID: 23289488
[TBL] [Abstract][Full Text] [Related]
20. The optimal lymph node dissection in patients with adenocarcinoma of the esophagogastric junction.
Okholm C; Fjederholt KT; Mortensen FV; Svendsen LB; Achiam MP
Surg Oncol; 2018 Mar; 27(1):36-43. PubMed ID: 29549902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
